Lineage Cell Therapeutics

-$0.04 (-1.96%) As of 4:21 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO
Brian M. Culley
Employees
55
Headquarters
Carlsbad, California
Founded
1990

LCTX Key Statistics

Market cap
380.10M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.13M
High today
$2.29
Low today
$2.22
Open price
$2.26
Volume
184.50K
52 Week high
$3.13
52 Week low
$1.55

LCTX Earnings

-$0.06
-$0.04
-$0.01
$0.01
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure